A carregar...
Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature
The present review aimed to assess the safety and efficacy of thalidomide and lenalidomide, two immunomodulatory drugs with anti-angiogenic properties, in women with recurrent ovarian, fallopian tube, and primary peritoneal cancer. A systematic review of the literature was conducted whereby Medline...
Na minha lista:
Publicado no: | Oncol Lett |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
D.A. Spandidos
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587990/ https://ncbi.nlm.nih.gov/pubmed/28927084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6578 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|